Smith & Nephew plc has completed the pricing of USD 350,000,000 5.150% Notes due 2027 and USD 650,000,000 5.400% Notes due 2034 (the "Notes"). The proceeds to Smith+Nephew (after expenses and underwriting discounts) of USD 990,630,650 from the Notes will be used to repay the amount outstanding under revolving credit facility (which drew down to fund the redemption in 2023 of 3.26% private placement notes due 2023, 3.89% private placement notes due 2024 and floating rate private placement notes due 2024 and in connection with recent acquisition of CartiHeal), to redeem at maturity 3.36% private placement notes due 2024, and otherwise for general corporate purposes. The offering is scheduled to close on March 20, 2024, subject to the satisfaction of customary conditions.